Most just lately, it's been identified that conolidine and the above mentioned derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in equivalent locations as classical opioid receptors, it binds to a big range of endogenous opioids. Compared with most opioid receptors, this receptor acts as a scavenger https://robertok198pmi4.bloggip.com/profile